SAFETY AND EFFICACY OF ESMOLOL (ASL-8052 - AN ULTRASHORT-ACTING BETA-ADRENERGIC BLOCKING-AGENT) FOR CONTROL OF VENTRICULAR RATE IN SUPRAVENTRICULAR TACHYCARDIAS

被引：48
作者：
BYRD, RC
SUNG, RJ
MARKS, J
PARMLEY, WW
机构：
[1] SAN FRANCISCO GEN HOSP,MED CTR,MED SERV,DIV CARDIOL,SAN FRANCISCO,CA 94110
[2] UNIV CALIF SAN FRANCISCO,DEPT MED,DIV CARDIOL,SAN FRANCISCO,CA 94143
[3] UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1984年 / 3卷 / 02期
关键词：
D O I：
10.1016/S0735-1097(84)80025-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：394 / 399
页数：6
相关论文
共 11 条
[1]  
AHLQUIST RP, 1977, AM HEART J, V93, P117
[2]   ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS PROPRANOLOL IN THE WOLFF-PARKINSON-WHITE SYNDROME [J].
BARRETT, PA ;
JORDAN, JL ;
MANDEL, WJ ;
YAMAGUCHI, I ;
LAKS, MM .
AMERICAN HEART JOURNAL, 1979, 98 (02) :213-224
[3]   EFFECTS OF PROPRANOLOL ON ANOMALOUS PATHWAY REFRACTORINESS AND CIRCUS MOVEMENT TACHYCARDIAS IN PATIENTS WITH PREEXCITATION [J].
DENES, P ;
CUMMINGS, JM ;
SIMPSON, R ;
WU, D ;
AMATYLEON, F ;
DHINGRA, R ;
ROSEN, KM .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (06) :1061-1067
[4]  
FITZ GERALD JD, 1969, CLIN PHARMACOL THER, V10, P292
[5]   CLINICAL PHARMACOLOGY OF THE NEW BETA-ADRENERGIC BLOCKING-DRUGS .3. COMPARATIVE CLINICAL-EXPERIENCE AND NEW THERAPEUTIC APPLICATIONS [J].
FRISHMAN, W ;
SILVERMAN, R .
AMERICAN HEART JOURNAL, 1979, 98 (01) :119-131
[6]   PHARMACOLOGY OF ASL-8052, A NOVEL BETA-ADRENERGIC-RECEPTOR ANTAGONIST WITH AN ULTRASHORT DURATION OF ACTION [J].
GORCZYNSKI, RJ ;
SHAFFER, JE ;
LEE, RJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1983, 5 (04) :668-677
[7]  
MURTHY VS, EUR J PHARM
[8]  
PAULOS M, 1983, CLIN RES, V31, pA212
[9]  
SUM CY, 1982, 33RD P NAT M AC PHAR
[10]   ESMOLOL - A PHARMACOKINETIC PROFILE OF A NEW CARDIOSELECTIVE BETA-BLOCKING AGENT [J].
YACOBI, A ;
KARTZINEL, R ;
LAI, CM ;
SUM, CY .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (06) :710-711
12